RA | Safety Data & Possible Side Effects | RITUXAN® (rituximab)
immediate and long-term side effects of rituximab administration | Download Table
Rituximab (Rituxan) Drug Information
Cardiac side effect of rituximab Patil VB, Lunge SB, Doshi BR - Indian J Drugs Dermatol
Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes - ScienceDirect
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial - The Lancet
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial - The Lancet
The importance of continuing with RITUXAN® (rituximab) for RA Patients
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective | Critical Care | Full Text
JCM | Free Full-Text | Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
Rituximab-induced lung disease: a systematic literature review | European Respiratory Society
GPA & MPA | RITUXAN® (rituximab) Safety on Follow Up Treatment
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial - The Lancet Respiratory Medicine
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial - The Lancet Neurology
Frequency of Rituximab related side effects. | Download Table
Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse | The Permanente Journal
RA | Safety Data & Possible Side Effects | RITUXAN® (rituximab)
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology
GVHD in pediatric HSCT patients: Clinical trials for Rituximab - Oncology Nurse Advisor
Rituximab-induced lung disease: a systematic literature review | European Respiratory Society
Rituximab in the treatment of skin diseases Rajagopalan M, Vasani R - Indian J Drugs Dermatol
PV | RITUXAN® (rituximab) Safety Data
